Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
09 2019
Historique:
received: 16 11 2018
revised: 01 04 2019
accepted: 08 04 2019
pubmed: 2 5 2019
medline: 9 6 2020
entrez: 2 5 2019
Statut: ppublish

Résumé

We aimed to identify predictors of left atrial appendage (LAA) thrombus in patients with atrial fibrillation (AF) and to enhance the prognostic value of the CHA Derivation cohort included 1033 consecutive AF patients referred for catheter ablation or direct current cardioversion, in whom transoesophageal echocardiography (TOE) was performed prior to the procedure. Logistic regression analysis was used to identify predictors of LAA thrombus on TOE. Receiver operating characteristic (ROC) curves were constructed to compare the newly developed score with the CHA On TOE, LAA thrombus was present in 59 (5.7%) patients in the derivation cohort. Aside from variables encompassed by the CHA In real-world AF patients with majority on oral anticoagulation, LAA thrombus was found in approximately 6%. Two variables not included in the CHA

Identifiants

pubmed: 31040170
pii: heartjnl-2018-314492
doi: 10.1136/heartjnl-2018-314492
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1310-1315

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Agnieszka Kapłon-Cieślicka (A)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Monika Budnik (M)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Monika Gawałko (M)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Michał Peller (M)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Iwona Gorczyca (I)

1st Department of Cardiology and Electrotherapy, Świętokrzyskie Cardiology Centre, Kielce, Poland.

Anna Michalska (A)

1st Department of Cardiology and Electrotherapy, Świętokrzyskie Cardiology Centre, Kielce, Poland.

Aldona Babiarz (A)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Aleksandra Bodys (A)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Robert Uliński (R)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Maciej Żochowski (M)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Piotr Scisło (P)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Janusz Kochanowski (J)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Krzysztof J Filipiak (KJ)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Grzegorz Opolski (G)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH